Patients typically start at 2mg
GLP-1 medications also suppress the release of glucagon, the hormone that raises blood sugar
GLP-1 RAs Hold Promising Potential for Reduction of Cardiometabolic Risk Factors additional benefits : Brain: Appetite suppression, nerve protection, and decreased neuroinflammation Heart: Decreased blood pressure (systolic and diastolic), reduced total cholesterol levels, lowered endothelial dysfunction, and increased heart rate Liver: Decreased glucose production Pancreas: Increased insulin secretion, decreased glucagon secretion, B islet cell proliferation GI Tract: Decreased gastric emptying Because these drugs cause weight loss, it is not clear whether the GLP-1 RAs or the weight loss reduces cardiometabolic risks
Taking a supplement intended to balance your hormones is likely a long-term commitment, so choosing a cost-effective option that fits into your budget is important
Do not stack DSIP with sedative medications without medical supervision